José Francisco Ramírez
Grup de recerca
- Patologia molecular inflamatòria i de tumors sòlids Accredited researcher (R3A)
Publicacions destacades
-
Quantitative Image Analysis of Fibrillar Collagens Reveals Novel Diagnostic and Prognostic Biomarkers and Histotype-Dependent Aberrant Mechanobiology in Lung Cancer
Autors:Referència: Modern Pathology 2023. -
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma
Autors:Referència: Matrix Biology 2022. -
Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer
Autors:Referència: International Journal Of Molecular Sciences 2022. -
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence
Autors:Referència: Cancer Letters 2021. -
Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
Autors:Referència: Lung Cancer 2019. -
Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer
Autors:Referència: Bmc Pulmonary Medicine 2019. -
Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery
Autors:Referència: Cancers 2019. -
The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases
Autors:Referència: Lung 2018. -
LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation
Autors:Referència: Journal Of Thoracic Oncology 2016. -
Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
Autors:Referència: American Journal Of Respiratory And Critical Care Medicine 2016.